Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
15.75    0.00 (0.00%)
Bid:
15.50
Ask:
16.00
Spread: 0.50 (3.226%)
Market Cap: £13.00m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Celerum launch first commercial product

11 Jan 2022 07:00

RNS Number : 9908X
Frontier IP Group plc
11 January 2022
Β 

Reach - a non-regulatory announcement

AIM: FIPP

11 January 2022

Β 

Frontier IP Group Plc

("Frontier IP" or the "Group")

Β 

Β 

Portfolio news - Celerum reaches significant milestone with launch of first commercial product

Β 

Frontier IP, a specialist in commercialising intellectual property, notes the following announcement that portfolio company Celerum Limited (the "Company") has launched Truck Logistics System, its first commercial product using novel artificial intelligence based on Nature Inspired Computing.

Β 

The Company has also won a first order from a road haulier for the software. The product uses artificial intelligence derived from natural processes and behaviours to maximise resources across logistics networks, cutting costs, carbon emissions and delivery times. Frontier IP holds a 33.8 per cent equity stake in Celerum.

Β 

Neil Crabb, Frontier IP Chief Executive Officer, said: "The launch of its first commercial software is an exciting development for Celerum. The need for companies to maximise the resource efficiency of their supply chains and logistics has been underlined by recent concerns over lorry driver shortages in the UK and the pressing need to minimise carbon emissions as part of initiatives to tackle climate change."Β 

Β 

Β 

Celerum statement begins:

Β 

Β 

Celerum launches AI-based Truck Logistics System to maximise efficiencies for small to medium sized fleets

Β 

Β 

Β· Celerum launches Truck Logistics System to cut road haulage costs, carbon emissions and delivery times - making logistics faster, greener and more efficient

Β 

Β· Wins first customer for software using the company's novel artificial intelligence based on Nature Inspired Computing

Β 

Celerum today announces the launch of its first commercially available product based on its novel Nature Inspired Computing (NIC) artificial intelligence to improve the efficiency of supply chains and logistics. The company's Truck Logistics System has also won its first customer.

Β 

Truck Logistics System is aimed at companies operating small to medium-sized truck fleets, such as road hauliers, suppliers and retailers. Such firms are still typically dependent on manual processes or Excel spreadsheets to organise their operations, lacking the resources to develop the bespoke systems used by bigger companies.

Β 

Celerum's software is easy to implement. It is cloud based and runs on standard computers with drivers able to interact with the system via their smartphones. It allows controllers to plan more effectively and to manage resources in real time, so they can optimise load capacity, drivers and route selection in response to changing conditions. As a result, they can cut costs and carbon emissions. The first customer is a road haulier operating a fleet of about 75 trucks and 150 trailers in the north of the UK.

Β 

The technology is based on more than 25 years' research into NIC by Celerum founder and chairman Professor John McCall, Head of Research at the National Subsea Centre at Robert Gordon University, Aberdeen.

Nature Inspired Computing creates algorithms using lessons from the natural world where evolution has overcome inefficiency. For example, bees and ants are extremely good at finding the best routes to food sources or returning to their nests.

Β 

A pilot project including Celerum organised by Highlands and Islands Enterprise found that NIC-based artificial intelligence cut carbon emissions by up to 40 per cent across food and drink supply chains when allied to behavioural changes such as load sharing between producers and hauliers. A wider ranging follow up project is now being planned.

Β 

Professor John McCall, Founder and Chairman of Celerum, said: "Truck Logistics System has the potential to transform operational efficiency for hundreds of companies currently running their van and truck fleets using manual processes or spreadsheets. The fact it has already won a customer gives us every hope for further success. However, TLS is only the first commercial application of our NIC-based AI and we are confident it will be able to help solve a host of other supply chain and logistics problems."

Β 

Celerum statement ends

Β 

Β 

Β 

ENQUIRIES

Β 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive Officer

Andrew Johnson, Communications and investor relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

Β 

Β 

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

Β 

Β 

Β 

T: 0203 328 5656

Β 

Β 

Β 

Β 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

Β 

This is a Reach announcement. Reach is anΒ investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies toΒ distributeΒ media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

Β 

Β 

Β 

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAGZGMMRGLGZZM
Date   Source Headline
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.